209 related articles for article (PubMed ID: 26936756)
1. Cluster analysis and its application to healthcare claims data: a study of end-stage renal disease patients who initiated hemodialysis.
Liao M; Li Y; Kianifard F; Obi E; Arcona S
BMC Nephrol; 2016 Mar; 17():25. PubMed ID: 26936756
[TBL] [Abstract][Full Text] [Related]
2. Cost comparison of peritoneal dialysis versus hemodialysis in end-stage renal disease.
Berger A; Edelsberg J; Inglese GW; Bhattacharyya SK; Oster G
Am J Manag Care; 2009 Aug; 15(8):509-18. PubMed ID: 19670954
[TBL] [Abstract][Full Text] [Related]
3. Can dialysis patients be accurately identified using healthcare claims data?
Taneja C; Berger A; Inglese GW; Lamerato L; Sloand JA; Wolff GG; Sheehan M; Oster G
Perit Dial Int; 2014; 34(6):643-51. PubMed ID: 24497600
[TBL] [Abstract][Full Text] [Related]
4. Chronic kidney disease: the distribution of health care dollars.
St Peter WL; Khan SS; Ebben JP; Pereira BJ; Collins AJ
Kidney Int; 2004 Jul; 66(1):313-21. PubMed ID: 15200439
[TBL] [Abstract][Full Text] [Related]
5. Direct medical costs of end-stage kidney disease and renal replacement therapy: a cohort study in Guangzhou City, southern China.
Zhang H; Zhang C; Zhu S; Ye H; Zhang D
BMC Health Serv Res; 2020 Feb; 20(1):122. PubMed ID: 32059726
[TBL] [Abstract][Full Text] [Related]
6. Healthcare costs of the progression of chronic kidney disease and different dialysis techniques estimated through administrative database analysis.
Roggeri A; Roggeri DP; Zocchetti C; Bersani M; Conte F; ;
J Nephrol; 2017 Apr; 30(2):263-269. PubMed ID: 27165160
[TBL] [Abstract][Full Text] [Related]
7. Association of Medicare's Bundled Payment Reform With Changes in Use of Vitamin D Among Patients Receiving Maintenance Hemodialysis: An Interrupted Time-Series Analysis.
Spoendlin J; Schneeweiss S; Tsacogianis T; Paik JM; Fischer MA; Kim SC; Desai RJ
Am J Kidney Dis; 2018 Aug; 72(2):178-187. PubMed ID: 29891194
[TBL] [Abstract][Full Text] [Related]
8. Clinical and economic outcomes of Staphylococcus aureus septicemia in ESRD patients receiving hemodialysis.
Nissenson AR; Dylan ML; Griffiths RI; Yu HT; Dean BB; Danese MD; Dubois RW
Am J Kidney Dis; 2005 Aug; 46(2):301-8. PubMed ID: 16112049
[TBL] [Abstract][Full Text] [Related]
9. The cost of hemodialysis in Iran.
Arefzadeh A; Lessanpezeshki M; Seifi S
Saudi J Kidney Dis Transpl; 2009 Mar; 20(2):307-11. PubMed ID: 19237828
[TBL] [Abstract][Full Text] [Related]
10. Comparing VA and private sector healthcare costs for end-stage renal disease.
Hynes DM; Stroupe KT; Fischer MJ; Reda DJ; Manning W; Browning MM; Huo Z; Saban K; Kaufman JS;
Med Care; 2012 Feb; 50(2):161-70. PubMed ID: 21945972
[TBL] [Abstract][Full Text] [Related]
11. Nondialysis (home) medication utilization and cost in diabetic and nondiabetic hemodialysis patients.
Manley HJ; Cannella CA
Nephrol News Issues; 2005 Jan; 19(2):27-8, 33-4, 36-8. PubMed ID: 15717572
[TBL] [Abstract][Full Text] [Related]
12. Economic evaluation of palliative management versus peritoneal dialysis and hemodialysis for end-stage renal disease: evidence for coverage decisions in Thailand.
Teerawattananon Y; Mugford M; Tangcharoensathien V
Value Health; 2007; 10(1):61-72. PubMed ID: 17261117
[TBL] [Abstract][Full Text] [Related]
13. Impact of initial dialysis modality and modality switches on Medicare expenditures of end-stage renal disease patients.
Shih YC; Guo A; Just PM; Mujais S
Kidney Int; 2005 Jul; 68(1):319-29. PubMed ID: 15954923
[TBL] [Abstract][Full Text] [Related]
14. Health care costs of peritoneal dialysis technique failure and dialysis modality switching.
Chui BK; Manns B; Pannu N; Dong J; Wiebe N; Jindal K; Klarenbach SW
Am J Kidney Dis; 2013 Jan; 61(1):104-11. PubMed ID: 22901772
[TBL] [Abstract][Full Text] [Related]
15. Exploring kidney dialysis costs in the United States: a scoping review.
Stewart F; Kistler K; Du Y; Singh RR; Dean BB; Kong SX
J Med Econ; 2024; 27(1):618-625. PubMed ID: 38605648
[TBL] [Abstract][Full Text] [Related]
16. Impact of Renal Disease on Patients with Hepatitis C: A Retrospective Analysis of Disease Burden, Clinical Outcomes, and Health Care Utilization and Cost.
Solid CA; Peter SA; Natwick T; Guo H; Collins AJ; Arduino JM
Nephron; 2017; 136(2):54-61. PubMed ID: 28214902
[TBL] [Abstract][Full Text] [Related]
17. The clinical and economic burden of pneumonia in patients enrolled in Medicare receiving dialysis: a retrospective, observational cohort study.
Sibbel S; Sato R; Hunt A; Turenne W; Brunelli SM
BMC Nephrol; 2016 Dec; 17(1):199. PubMed ID: 27955633
[TBL] [Abstract][Full Text] [Related]
18. Is CAPD a viable option among ADPKD with end stage renal disease population in India? Its outcomes and economics.
Kaul A; Dharshan R; Bhadhuaria D; Prasad N; Gupta A; Sharma RK
Saudi J Kidney Dis Transpl; 2015 Sep; 26(5):906-11. PubMed ID: 26354561
[TBL] [Abstract][Full Text] [Related]
19. Hemodialysis versus peritoneal dialysis, which is cost-effective?
Atapour A; Eshaghian A; Taheri D; Dolatkhah S
Saudi J Kidney Dis Transpl; 2015 Sep; 26(5):962-5. PubMed ID: 26354569
[TBL] [Abstract][Full Text] [Related]
20. End-stage renal disease-financial costs and years of life lost in Panama: a cost-analysis study.
Moreno Velásquez I; Tribaldos Causadias M; Valdés R; Gómez B; Motta J; Cuero C; Herrera-Ballesteros V
BMJ Open; 2019 May; 9(5):e027229. PubMed ID: 31133590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
